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Antiglomerular basement membrane antibody: Antibody specificity in
different forms of glomerwonephritis. Components were solubilized
from human glomerular basement membrane by digestion with collage-
nase and pepsin or by extraction with guanidine-HCI either directly or
after previous digestion with the enzyme. The diverse preparations
were used as antigens in the enzyme-linked immunosorbent assay
(ELISA) of antibody titers in sera from patients with Goodpasture
syndrome and patients with other forms of gfomerulonephritis, that is,
systemic lupus erythematosus, periarteritis nodosa, and IgA-related
nephropathy. Patients with Goodpasture syndrome had high titers of
IgG antibodies reacting most strongly with collagenase digests. The
antigen(s) was only partly solubilized by guanidine-HCI extraction, was
destroyed by pepsin digestion as well as reduction, and partly destroyed
by trypsin digestion. The antigen(s) is most likely noncollagneous
protein. Antibodies from patients with other forms of nephritis were
directed primarily against antigens in guanidine-HCI extracts, while the
antigen(s) was not solubilized by collagenase digestion. Pepsin diges-
tion destroyed the antigen(s). The antibodies were of a different class,
that is, the patients with systemic lupus erythematosus had IgG and IgA
as well as 1gM antibodies; the patients with periarteritis nodosa had 1gM
or lgG and IgA antibodies, while the patients with IgA-related nephritis
had the highest recorded titers of IgA but also had IgG as well as 1gM
antibodies. None of the patients had antibodies directed against triple
helical collagen. The antibody response in anti-GBM antibody-related
nephritis, then, is different both with respect to antigen and antibody
class and depends on the underlying disease syndrome.
Anticorpsanti-membrane basale glomérulaire: Spécificité des anticorps
dans différentes formes de gIomérulonephrites Les constituants de
membranes basales glomérulaires humaines ont été solubilisés par
digestion avec de Ia collagenase et de Ia pepsine ou par extraction avec
de Ia guanidine-HCI directement ou après digestion prealable par
l'enzyme. Ces diverses preparations ont été utilisées comme antigène
dans La titration d'anticorps par essai immunosorbant relies par enzyme
(ELISA) dans des serums de malades ayant un syndrome de Goodpas-
ture, et de malades avec d'autres formes de glomérulonephrites,
notamment lupus erythemateux disséminé, périartCrite noueuse, et
néphropathie a IgA. Les malades ayant un syndrome de Goodpasture
avaient des titres élevés d'anticorps IgG réagissant trés fortement avec
des produits de digestion de collagenase. L'antigene(s) était seulement
partiellement solubilisé par extraction a Ia guanidine-HCI, était détruit
par Ia digestion par Ia pepsine et par reduction, et était partiellement
détruit par digestion a Ia trypsine. L'antigene(s) est probablement une
protéine noncollagéne. Les anticorps provenant de malades ayant
d'autres formes de néphrites étaient essentiellement diriges contre des
antigénes provenant d'extraits guanidine-HCI, tandis que l'antigene(s)
n'était pas solubilisé par digestion a Ia collagenase. La digestion par Ia
pepsine a détruit l'antigene(s). Les anticorps étaient de différentes
classes, les malades ayant un lupus erythemateux disseminé avaient des
IgG, des IgA, et des 1gM comme anticorps; les malades ayant une
périartérite noueuse avaient des anticorps 1gM, IgG, IgA, alors que les
malades ayant une nephrite a IgA avaient les titres les plus élevés
d'anticorps IgA, mais avaient egalement des IgG et des 1gM. Aucun des
malades n'avait d'anticorps diriges contre du collagene a triple hélice.
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La reponse anticorps dans la néphrite Iiée it un anticorps anti-GBM est
donc différente par Ia classe d'antigenes ou d'anticorps en fonction du
syndrome sous-jacent.
Available data show that antiglomerular basement membrane
antibodies (anti-GBM antibodies) have a role in the pathogene-
sis of Goodpasture syndrome (GP) [I]. Kidney biopsy speci-
mens from such patients show a linear nephritis on immunofluo-
rescence microscopy [2]. In most cases circulating anti-GBM
antibodies can be demonstrated using either indirect immuno-
fluorescence microscopy [2], radioimmunoassay (RIA) [3—5] or
enzyme-linked immunosorbent assay (ELISA) [6]. The charac-
ter of the antigen or antigens reacting with anti-GBM antibodies
have not been determined. Collagen as well as noncollagen
glycoproteins of the glomerular basement membrane (GBM)
have been proposed to contain the antigenic sites responsible
for immunization [4, 71. More recently, some patients, who do
not fulfill the clinical criteria of Goodpasture syndrome have
been shown to have circulating anti-GBM antibodies [8]. Stud-
ies in our laboratory, using ELISA, have confirmed this finding
and indicated that the specificity as well as the immunoglobulin
class of the anti-GBM antibodies may vary with the underlying
disease [9, 101. Therefore, the character of antigens used in
assays of anti-GBM antibodies is important.
This study was designed to compare the efficiency of several
GBM preparations to show the specificity of anti-GBM antibod-
ies in sera from a number of patients representing several
defined clinical syndromes.
Methods
ELISA. IgG, IgA, and 1gM antibodies reacting with isolated
human glomerular basement membrane antigens were mea-
sured using ELISA, as described elsewhere [6, 10]. In essence,
antigens (200 z1, 10 jg/ml) dissolved in 0.05 mole/liter sodium
carbonate, pH 9.6, containing 0.05% sodium azide were coated
on wells in polystyrene microtiter plates (Nunc Immunoplate,
Roskilde, Denmark) by incubation at 22°C for 16 hr. To obtain
optimal coating with type IV collagen, however, this antigen
was solubilized in 0.5 mole/liter acetic acid as previously
described [ill. The wells were rinsed threefold in 0.15 mole/
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liter sodium chloride, 0.05% (v/v) Tween 20. Dilutions (1/20,
200 1.d) of patient or control sera in 0.05 mole/liter sodium
phosphate buffer pH 7.4, 0.15 mole/liter sodium chloride, were
added and incubated at 4°C for 6 hr. The wells were rinsed as
above and suitable dilutions [200 .tl in 0.15 mole/liter sodium
chloride, 0.05 mole/liter sodium phosphate buffer, pH 7.4,
0.05% (v/v) Tween 20, 2 g/liter of bovine serum albumin] of
swine antihuman IgG, IgA, or 1gM conjugated to alkaline
phosphatase (conjugates from Orion Diagnostica, Helsinki,
Finland) were added. After incubations for 16 hr at 4°C, the
plates were rinsed as above and enzyme substrate (200 sl/well),
p-nitro-phenylphosphate (Sigma Chemical Corp., St. Louis,
Missouri) in 1 mole/liter diethanolamine buffer, pH 9.8 contain-
ing 5 mmoles/Iiter magnesium chloride, was added. The colored
reaction product obtained after incubation (22°C, 1 hr) is
proportional to the content of specific antibody in the sera
tested. A Titertec Multiscan spectrophotometer (Flow Labora-
tories, McLean, Virginia) equipped with a 405-nm filter was
used for absorbance measurements. The specificity of the
conjugates were tested and no crossreactivity between Ig-class
(IgG, IgA, and 1gM) could be demonstrated using ELISA.
Preparation of antigens from GBM. The different antigens
used in this study were prepared from GBM as summarized in
the flow diagram, Figure 1. Details are given below.
Preparation of human glomerular basement membrane. Hu-
man cadaver kidneys were obtained at autopsy within 24 hr
after death. Glomerular basement membrane was prepared
essentially as described by Westberg and Michael [12]. The
following protease inhibitors were included in all steps of the
preparations: Benzamidine-HCI 5 mmoles/liter, 6-aminohexa-
noic acid 25 mmoles/Iiter, EDTA 10 mmoles/liter, phenylmeth-
anesulfonylfluoride I mmole/liter. N-ethylmaleimide, 5 mmoles/
liter, served a dual function as a protease inhibitor and to
prevent disulphide exchange.
Collagenase digestion. Bacterial collagenase (Type CLS,
Worthington, Freehold, New Jersey), purified according to
Lee-Own and Anderson [131, was used to digest GBM at 37°C
for 72 hr [6. 10]. Lyophilized GBM was suspended (5 mg/mI) in
0.05 mole/liter Hepes buffer, pH 7.45, containing 0.01 mole/liter
calcium chloride, and all protease inhibitors but EDTA, at
concentrations described above. A residual pellet after guani-
dine-HCI extraction of GBM was dialyzed extensively against
the buffer and then digested. After digestion preparations were
centrifuged at x l00,000g for 1 hr, and the supernatants were
used as antigens in ELISA.
Trypsin digestion. GBM was solubilized by collagenase di-
gestion, extensively dialyzed against 0.1 mole/liter sodium
phosphate buffer, pH 7.6, and digested with diphenylcarbamyl
chloride-treated trypsin (Sigma) at a ratio of trypsin to substrate
of 1:50. Digestion was carried out at 37°C for 4 hr. The digest
was clarified by centrifugation at x lOO,000g for 1 hr, and the
supernatant was used as an antigen in ELISA.
Pepsin digestion and isolation of type IV collagen. GBM was
suspended in 0.5 mole/liter acetic acid and digested with pepsin
(Sigma) at 4°C for 16 hr at a ratio of enzyme to dry weight GBM
of 1:50. The digest was centrifuged at X lOO,000g for I hr, and
the supernatant was directly used as an antigen or for the
preparation of type IV collagen as described previously [6, Il].
Guanidine-HCI extraction of GBM antigens, Lyophilized
GBM was extracted at 3 mg/mI and 42°C for 18 hr with 6
moles/liter guanidine-HCI, 0.05 mole/liter Tris-HCI, pH 7.5,
also containing the protease inhibitors listed above for the
preparation of GBM. Residual pellets after collagenase diges-
tion and pepsin digestion, respectively, were similarly extracted
with guanidine-HCI. The extracts were clarified by centrifuga-
tion at x l00,000g for 1 hr before use in ELISA.
Reduction and alkylation cf antigens. Selected antigens,
indicated in Figure 1, were reduced, alkylated, and tested for
immunoreactivity in ELISA. Solubilized components were
dialyzed extensively against 6 moles/liter guanidine-IICI, 0.05
mole/liter Tris-HCI, pH 7.5. Reduction of these components
was performed at 37°C for 5 hr with less than 0.5 mg of protein
per ml of 5 mmoles/liter dithiothreitol. After 5 hr iodoacetic acid
(threefold excess) was added, and alkylation was carried out
overnight at room temperature.
Precipitation with ethanol of extracts and digests. Macromol-
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Table 1. Contents of collagen (hydroxyproline) and total protein (a-
amino nitrogen) in antigenic components prepared as described in
Figure 1
Hydroxyproline
a-Amino nitrogen
Molar ratio x 100 Arbitrary units
GBM 5.2 1.00
GBM:C 1.8 0.34
GBMCrsidue, Gu 5.3 1.03
GBM:P 5.3 1.04
Type IV collagen 6.4 1.23
GBM:Prejdue, Gu 4.8 0.92
GBM:Gu 3.3 0.63
GBM:Guresjth,e, C 2.7 0.52
ecules solubilized by enzyme digestion or by extraction with
guanidine-HCI were precipitated with 10 volumes of 95% etha-
no! at 4°C and left overnight. The precipitates were recovered
by centrifugation at x2000g for 30 mm at 22°C.
Quantitation of collagen (hydroxyproline) and total protein
(a-amino nitrogen). The hydroxyproline contents of GBM and
antigens precipitated with ethanol were determined colorimetri-
cally according to Stegemann and Stalder [14] after hydrolysis
of samples in 6 moles/liter HC1 for 24 hr at 104°C. Protein (a-
amino nitrogen) contents of GBM or antigens precipitated with
ethanol were determined by the ninhydrin procedure [151 after
hydrolysis of samples in 6 moles/liter HC1 for 24 hr at 104°C
[151.
Electrophoresis. Sodium dodecyl sulphate (SDS)-polyacryl-
amide gel electrophoresis was done essentially according to
Laemmli [16] as previously described [10, 11]. Samples to be
electrophoresed were precipitated with 10 volumes of ethanol
and redissolved in sample gel buffer containing 2% SDS with or
without 1% mercapto-ethanol.
Patients. Thirty-two patients were included in the present
study. Eighteen patients represented classical Goodpasture
syndrome having lung purpura, rapidly progressive glomerulo-
nephritis, and crescentic glomerulonephritis on light microsco-
py. Serum samples from these patients were obtained from
several nephrology centers in Sweden and Denmark. In all
patients diagnosis had been confirmed by the finding of a linear
pattern upon immunofluorescence microscopy. Circulating
anti-GBM antibodies were also demonstrated by indirect immu-
nofluorescence microscopy using normal kidney sections. Pa-
tients with other types of nephritis and having antibodies to
basement membrane were obtained from an ongoing study on
glomerulonephritis at the Department of Nephrology, Universi-
ty Hospital, Lund (to be published). Seven patients had system-
ic lupus erythematosus with multiorgan involvement, a positive
ANF titer, and low levels of complement. Two patients had
multiorgan vasculitis and glomerulonephritis. They were diag-
nosed as having periarteritis nodosa. The immunofluorescence
pattern was granular in the nine non-Goodpasture patients with
systemic connective tissue disease, indicative of immuno-com-
plex-related glomerulonephritis [2]. Five patients had IgA-
related glomerulonephritis, focal glomerulonephritis on light
microscopy, and mesangially localized IgA and C'3 predomi-
nating on immunofluorescence microscopy. Reactivities of sera
from individuals without disease were determined using 25
blood samples from blood donors.
Results
Enzyme-linked immunosorbent assay (ELISA). The precision
and reproducibility of ELISA of antibodies against two of the
antigens used in this study, GBM antigens solubilized by
collagenase digestion and extracted with guanidine-HCI, re-
spectively, have been reported previously [6, 10]. The coeffi-
cient of variation was 6%, mainly due to variable coating and
the release of antigens from the polystyrene plates during assay.
Preparations of antigens for ELISA. It was assumed that if a
large number of antigenic preparations were tested, the chances
of discerning specificity for different antigens by the patient's
antibodies would be larger. Therefore several procedures were
used to solubilize antigens: (1) proteolytic cleavage of nontriple
helical proteins by pepsin to solubilize primarily collagen triple
helical fragments; (2) specific proteolytic cleavage of triple
helical collagen with purified collagenase to liberate proteins
other than triple helical collagen; and (3) extraction with
guanidine-HCI to release noncovalently bound molecules. Se-
quential extraction with the different procedures as indicated in
Figure 1 was used to allow improved extraction, for instance,
after the collagen network of the tissue had been destroyed by
collagenase. Furthermore, such procedures may allow selective
preparation of purer proteins, better suited for purification of
the antigens, which is the ultimate goal of the project. In some
extracts proteins were unfolded by reduction and alkylation to
alter the number of reactive components and to provide infor-
mation on the protein nature of antigens. An outline of the
protocol for preparation of GBM-antigens to be used for
monitoring circulating antibodies is shown in Figure 1. Only
solubilized components were used for further studies.
Characterization of antigenic preparations. Using the condi-
tions described, approximately 75% (by weight) of the GBM
was solubilized by digestion with bacterial collagenase, approx-
imately 60% by digestion with pepsin, and approximately 50%
was extracted with guanidine-HC1. Solubilized macromolecules
were characterized after precipitation with ethanol. Small pep-
tides, protease inhibitors, and salts present in digests or ex-
tracts are not precipitated and do therefore not interfere in the
analyses. The composition, then, reflects larger polypep-
tides, including those being immunoreactive. The ratio of
hydroxyproline to a-amino nitrogen (total protein) indicates the
proportions of collagen to total protein in the precipitates, Table
1. Collagenase digests contained mostly noncollagenous pro-
teins and only small amounts of collagen. It is likely that
collagenous peptides liberated during digestion are too small to
be precipitated with ethanol. Pepsin digests, on the other hand,
contained collagen, which was further enriched by salt precipi-
tation used to purify type IV collagen, Table 1. Direct extracts
of GBM with guanidine-HCI released noncollagen proteins and
some collagen as shown by the intermediary ratios, Table 1.
The guanidine-HC1 extracts of the residue after collagenase as
well as after pepsin digestion contained high proportions of
collagen.
Further information on the character of the antigens solubi-
lized by the procedures was obtained by using a rabbit antise-
rum specific for human type IV collagen [61 as well as a rabbit
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Fig. 2. The reactivity in ELISA of two rabbit antisera with antigens
prepared from GBM. The reactivity of a rabbit antiserum (antiglycopro-
tein), specific for noncollagenous domains of the GBM (black bars) and
the reactivity of specific rabbit anti-type IV collagen antiserum (open
bars). Absorbance values found with the pre-immune serum from the
same animal (background absorbance) were subtracted from the absor-
hance values found with immune sera.
antiserum specific for noncollagen proteins from GBM (anti-
glycoprotein) [61. Previous studies have shown that the antise-
rum directed against type IV collagen does not react with the
small peptides formed upon digestion of type IV collagen with
bacterial collagenase [61. The reactivities with the two antisera
of extracts and digests of GBM were determined using ELISA
(Fig. 2). Expectedly, all samples digested with collagenase
reacted strongly with antiglycoprotein antibodies, while show-
ing no reaction with antitype IV collagen antibodies. Samples
digested with pepsin, on the other hand, contained primarily
type IV collagen as shown by the strong reaction with the
relevant antiserum, while not reacting or reacting only weakly
with the antiglycoprotein antiserum. The guanidine-HCI ex-
tracts showed variable reactions. Direct extracts of samples not
previously digested contained components reacting with anti-
glycoprotein antibodies as well as with antitype IV collagen
antibodies. Collagen triple helical structures of samples treated
with collagenase were destroyed and did not react with antilype
IV collagen antibodies. The noncollagen proteins on the other
hand were destroyed by prior pepsin digestion and did not react
with antiglycoprotein antibodies (Fig. 2).
The patterns on SDS-PAGE of the collagenase digest and
guanidine-HCI extract of GBM, respectively, were quite com-
plex showing the presence of several components in both
preparations (Fig. 3).
ELISA of antibodies in ,sera from patients. Sera from patients
with various disease syndromes reacted differently with the
spectrum of antigens (Figs. 4 and 5). Notably, however, sera
from the patients with Goodpasture syndrome showed similar
reaction profiles. The serum from one patient with Goodpasture
syndrome was tested against all the antigen preparations. This
serum showed high titers in ELISA with all antigens solubilized
by collagenase digestion of GBM, regardless of prior extraction
with guanidine-HCI (Fig. 4). It is therefore likely that the
antigen or antigens involved in this disease are bound firmly
into the matrix of the basement membrane and require exten-
sive cleavage of the collagen network to be released. Antigens
solubilized by direct extraction of GBM with guanidine-HCI,
however, showed some reactivity with the serum, while pepsin
digestion appeared to destroy the antigen(s). None of the
samples isolated from pepsin digests reacted with serum from
patients with Goodpasture syndrome. The antigens therefore
were of a noncollagen nature. Since most of the immune
reactivity was lost on reduction and partly by digestion with
trypsin (Fig. 4), it appears that the antigen is protein in nature,
having a tertiary structure depending on disulphide bridges.
Altogether 18 patients with Goodpasture syndrome have had
IgG antibodies of variable titers reacting with antigen(s) solubi-
lized by collagenase digestion of GBM (Fig. 5). Ten sera from
patients with Goodpasture syndrome showed no reactivity [61.
when analyzed for antibodies against preparations solubilized
by pepsin digestion (type IV collagen).
Serum from one of the patients having systemic lupus erythe-
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Fig. 3. SDS-polyacrvlamide gel electrophoresis (6.25% gel) of antigen
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Fig. 4. The reactivities in ELISA of serum from a patient with
Goodpasture syndrome (upper panel) and serum from a patient with
systemic lupus erythematosus (lower panel) against 11 soluble GBM
preparations (indicated in Fig. 1). Symbols are: IgG antibody reactivity
(El); 1gM antibody reactivity (); IgA antibody reactivity (). The
mean absorbance values found for two normal sera in ELISA were
subtracted from the absorbance values found with the patient sera.
matosus with nephritis showed entirely different reactions with
the antigens (Fig. 4, lower panel). The antigen(s) could be
extracted with guanidine-HC1 and was insensitive to reduction.
The antigens were not released by digestion with collagenase,
but the residue contained reactive antigens which could be
solubilized by extraction with guanidine-HC1. Similarly the
antigen(s) was present in residues of GBM after pepsin diges-
tion and was extracted with guanidine-HCI (Fig. 4). This
antigen(s), then, is not extracted by the enzyme digestions,
although the structure of the GBM is altered extensively. It is
likely that the antigen(s) is an integral part of the basement
membrane rather than being a contaminant. It appears, howev-
er, to be bound in the membrane only by noncovalent bonds,
which can be dissociated by chaotropic agents, such as guani-
dine-HCI.
In subsequent experiments sera from patients with several
forms of nephritis and having antibasement membrane antibod-
ies have been analyzed for antibody specificity (Fig. 5). All the
sera react primarily with antigens solubilized with guanidine-
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Fig. 5. Circulating antibodies against GBM. Antigens were solubilized
with bacterial collagenase (GBM:C) and with 6 M guanidine-HCI
extraction (GBM:Gu). Values are expressed as a quotient (P/N) be-
tween the absorbance value found for the patient sera and the mean of
the absorbance values for three normal sera.
HCI. Subsequent experiments (Fig. 5), using guanidine-HCI
extracted antigens, show that patients with systemic lupus
erythematosus have variable IgG, IgA, and 1gM responses,
while patients with IgA-related nephritis primarily have IgA
antibodies. A few patients with periarteritis nodosa have vari-
able Ig responses against the guanidine-HCI-extracted antigens
(Fig. 5). Normal control subjects show insignificant reactivity
against GBM antigens tested. It should be stressed, that so far,
no patient has had circulating antibodies directed against anti-
gens in the pepsin digest, that is, against type IV collagen.
Discussion
Isolated basement membrane contains several components
potentially causing an antibody response. Chemically distin-
guishable structures are the triple helical collagen domains and
the nontriple helical protein domains, the latter probably being
glycoproteins and proteoglycans [17—19]. The two types of
structures contain a number of different components all bound
together via covalent bonds or noncovalent molecular interac-
tions [16, 171. Little is known of distinct components although a
few, that is, type IV collagen [17], laminin [20], 7s collagen [21],
and proteoglycans [19], have been identified. Animals immu-
nized with preparations of GBM develop a spectrum of antibod-
ies directed against several components [11, 22]. It has been
shown that arititype IV collagen antibodies as well as several
types of antiglycoprotein antibodies are produced in response
to such immunization [11, 22]. Some animals develop glomeru-
lonephritis mediated by the antibodies [11]. There are several
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problems in understanding such a model disease. The antigen
preparation may contain several components that have become
antigenic due to changes in structure as a result of the prepara-
tion procedure. Spontaneous anti-GBM antibody associated
nephritis on the other hand seems to occur only in humans [Ii.
Reports on the character of the antigens are conflicting and
collagen peptides, oligosaccharide side chain, as well as noncol-
lagen proteins, have been implicated [4, 7, 231. Most prepara-
tions studied, however, have been crude and the nature of the
true antigens is dubious.
The strategy chosen in the present investigation has been to
use several preparations of components solubilized from GBM
to select that preparation containing the antigen relevant to a
particular form of nephritis. The aim is to use such a prepara-
tion for purification of components reacting with the antibodies
present in the patient serum. The different extracts overlap with
regard to antigen contents. It should be stressed that it is
probably essential to include N-ethylmaleimide in extraction
solvents, particularly when guanidine-HCI is used, to avoid
disuiphide exchange causing problems in the subsequent purifi-
cation of antigens.
An important observation in the present study is the different
character of the antigen(s) involved in Goodpasture syndrome
as compared to those involved in other forms of nephritis.
Although both types of antigens represent structures not con-
taining the triple helical portions of collagen, they are markedly
different with respect to sensitivity to chemical modifications.
Only the antigen reacting with the IgG antibodies present in
sera from several patients with Goodpasture syndrome is
sensitive to reduction.
The localization of the different antigens in the GBM remains
essentially unknown. The present study may, however, provide
some clues. Good yields of antigens reacting with antibodies in
sera from patients with Goodpasture syndrome was obtained
only with drastic destruction of the structure of the basement
membrane using collagenase digestion. This finding may be
expected since immunoelectron microscopy [241 and epi-immu-
nofluorescence microscopy [251 indicate that the antigenic sites
are located in the lamina densa. The pathogenic significance of
the antibodies present in sera from patients with systemic lupus
erythematosus or periarteritis nodosa is more doubtful. Nephri-
tis has usually been ascribed to circulating immune complexes,
frequently observed [I]. Partially linear patterns of immuno-
globulins and complement have, however, been observed,
indicating a more complex genesis [261. Furthermore, in more
recent studies circulating antibodies of lgG directed against
GBM-antigens have been demonstrated using RIA [81.
The demonstration of circulating antibodies directed against
glomerular basement membrane antigens, indicates that such
antibodies may be involved at least in the progression of the
disease. The antigens are extracted with guanidine-HCI and are
bound via noncovalent bonds into the basement membrane.
According to Huang [27], only basement membrane structures
of endothelial and mesangial origin change upon treatment with
guanidine-HCI. It is therefore possible that the antigens reacting
with IgA, 1gM and/or IgG antibodies in sera from patients
having other forms of nephritis are located in lamina rara or in
mesangial regions and are of endothelial origin.
In systemic lupus erythematosus antibodies against various
auto-antigens, including nuclear antigens, are common. The
antibodies studied in this report, however, appear to be directed
against basement membrane structural components. As dis-
cussed above, it appears that the antigens detected are an-
chored tightly in the basement membrane and therefore proba-
bly do not represent extraneous molecules. Further support for
the contention that these antigens represent basement mem-
brane components, rather than cellular material, was provided
by the identical reactivities of extracts of GBM preparations
made by the procedure of Meezan et al [28] which includes
extraction with detergents and digestion with DNA'se (data not
shown), Furthermore, the serum from one patient with system-
ic lupus erythematosus had high anti-DNA antibody titers, but
did not react in the ELISA against GBM-antigens.
Another important observation is the presence in sera from
patients with IgA nephritis [29] of IgA antibodies reacting most
markedly with antigens present in guanidine-HCI extracts of
GBM. The etiology of IgA nephritis is unknown and subgroups
where auto-immune antibodies have pathophysiological signifi-
cance may exist.
By using antigens solubilized with collagenase, an anti-GBM
antibody assay specific for Goodpasture syndrome is obtained.
In contrast, antigens solubilized with chaotropic agents, al-
though reacting with sera from patients with Goodpasture
syndrome, will also react with sera from patients with other
forms of renal disease. Therefore, the clinical specificity of anti-
GBM antibody assays is highly dependent on the antigen
preparations used. Future studies using purified antigens may
provide further diagnostic aid and show that the specificity of
the antibodies may vary with the disease.
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